Adverse events of inactivated COVID-19 vaccine in HIV-infected adults

This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Songjie, Zhang, Yubin, Ming, Fangzhao, Zou, Shi, Wu, Mengmeng, Guo, Wei, Tang, Weiming, Liang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643182/
https://www.ncbi.nlm.nih.gov/pubmed/34863210
http://dx.doi.org/10.1186/s12981-021-00416-1
Descripción
Sumario:This study aims to evaluate the safety of inactivated COVID-19 vaccine among adult people living with HIV (PLWH). In total, 259 PLWH who received at least one dose of inactivated COVID-19 vaccine were enrolled, and post-vaccination adverse events (AEs) were evaluated seven days following each vaccination dose. The overall AE frequency was 22.8% after dose one, which was higher than after dose two (10.2%) (P < 0.001). No severe side event or vaccine safety concern was observed. Our finding was essential in reducing vaccine hesitancy among PLWH.

Ejemplares similares